GSH, in particular, would act as a neuroprotective agent binding Cis-DDP and other platinum compounds such as oxaliplatin, preventing the first step of neuronal damage that is platinum accumulation in peripheral nerves [105,106]
Plan sponsors are encouraged to review their coverage for GLP-1 drugs and consider how they handle drugs with multiple indications. Read more coverage of the 2025 Face to Face Drug Plan Management Forum.
[52] The lysine at GLP position 26 (semaglutide position 20) has a long chain attached, ending with a chain of 18 carbon atoms and a carboxyl group
Liposomal delivery (wrapping the molecule in a phospholipid bilayer) is an established drug-delivery approach for improving the survival of fragile compounds through digestion
Given that only one of eight large, randomized trials has demonstrated an increased risk of amputations it is unlikely that SGLT2 inhibitors significantly increase the risk of amputations
The FDA does not regulate supplements, so be sure to choose brands that have been tested by a third party if youre encouraged to try cardamom supplements by a healthcare provider
